UFP Technologies, Inc. (UFPT)
| Market Cap | 1.51B |
| Revenue (ttm) | 602.80M |
| Net Income (ttm) | 68.31M |
| Shares Out | 7.71M |
| EPS (ttm) | 8.75 |
| PE Ratio | 22.31 |
| Forward PE | 20.56 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 163,990 |
| Open | 197.30 |
| Previous Close | 197.30 |
| Day's Range | 193.74 - 201.99 |
| 52-Week Range | 182.87 - 274.93 |
| Beta | 1.17 |
| Analysts | Strong Buy |
| Price Target | 289.00 (+48.19%) |
| Earnings Date | May 1, 2026 |
About UFPT
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing. It also offers equipment ... [Read more]
Financial Performance
In 2025, UFP Technologies's revenue was $602.80 million, an increase of 19.50% compared to the previous year's $504.42 million. Earnings were $68.31 million, an increase of 15.82%.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for UFPT stock is "Strong Buy" and the 12-month stock price target is $289.0.
News
UFP Technologies Transcript: 47th Annual Raymond James Institutional Investor Conference
A leading CDMO in medical devices leverages exclusive material access, strategic acquisitions, and deep customer partnerships to drive high-margin growth. Recent contract extensions, robust financial performance, and expansion into new geographies position the company for continued outperformance.
UFP Technologies to Present and Host 1X1 Investor Meetings at the Raymond James 47th Annual Institutional Investors Conference
NEWBURYPORT, Mass., Feb. 27, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
UFP Technologies Earnings Call Transcript: Q4 2025
Revenue grew 19.5% to $602.8M, with strong gains in operating income and EPS. Labor inefficiencies and a cybersecurity breach were managed effectively, and robust growth is expected in patient services and medical submarkets, supported by contract extensions and facility expansions.
UFP Technologies Announces Record 2025 Results
NEWBURYPORT, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
UFP Technologies to Report Fourth Quarter and Year-End 2025 Financial Results on February 24, 2026
NEWBURYPORT, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
UFP Technologies Transcript: Piper Sandler 37th Annual Healthcare Conference
A Medtech-focused CDMO with $600M revenue leverages exclusive material access, custom engineering, and strategic acquisitions to drive double-digit growth in high-value markets. Long-term contracts, strong customer relationships, and a proven management team underpin robust financial targets and sustained outperformance.
UFP Technologies Announces CEO Succession Plan
NEWBURYPORT, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
UFP Technologies to Present and Host 1X1 Investor Meetings at the Piper Sandler 37th Annual Healthcare Conference
NEWBURYPORT, Mass., Nov. 25, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT) a contract development and manufacturing organization that specializes in single-use and single-patient medi...
UFP Technologies Earnings Call Transcript: Q3 2025
Q3 sales grew 6.5% to $154.6M, led by MedTech and strong segment growth, despite a $3M labor inefficiency at AJR that reduced margins and EPS. Backlog remains high, with new programs and contract expansions expected to drive future growth.
UFP Technologies Announces Strong Q3 2025 Results
NEWBURYPORT, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
UFP Technologies to Report Third Quarter 2025 Financial Results on November 3, 2025
NEWBURYPORT, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
UFP Technologies Transcript: 16th Annual Midwest Ideas Conference
A leading CDMO in medical devices, the company leverages early client engagement, strategic acquisitions, and technical expertise to drive high-margin growth in a $100 billion, fast-growing, and fragmented market. Recent acquisitions and strong client relationships support robust financial targets and continued expansion.
UFP Technologies to Present and Host 1x1 Investor Meetings at the 16th Annual Midwest IDEAS Investor Conference on August 26th in Chicago, IL
NEWBURYPORT, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (UFPT), today announced Mitch Rock, President, and Ron Lataille, Sr. VP and CFO, will present at the Midwest IDEAS Investor...
UFP Technologies Earnings Call Transcript: Q2 2025
Q2 2025 saw 37% revenue growth, strong medical and robotics performance, and robust cash flow. Labor inefficiencies at AJR impacted margins, but improvement is expected in Q4. Strategic acquisitions and expansion in the Dominican Republic support future growth.
UFP Technologies Announces Record Q2 Results
NEWBURYPORT, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
UFP Technologies to Report Second Quarter 2025 Financial Results on August 4, 2025
NEWBURYPORT, Mass., July 29, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient med...
Trout Capital Advisors Serves as Exclusive Financial Advisor to Universal Plastics & Engineering Company in Sale to UFP Technologies
LANCASTER, Pa. , July 29, 2025 /PRNewswire/ -- Trout Capital Advisors, LLC ("TCA"), a leading lower-middle market investment banking firm, is pleased to announce it served as the exclusive financial a...
UFP Technologies Acquires UNIPEC and TPI to Expand Film and Thermoplastic Molding Capabilities
NEWBURYPORT, Mass., July 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and o...
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the CJS Securities 25th Annual Summer Conference
NEWBURYPORT, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), today announced that Mitchell Rock, President, and Ron Lataille, Sr. Vice President & CFO, will present and...
UFP Technologies Transcript: The 15th Annual East Coast IDEAS Conference
The presentation highlighted a strong growth trajectory driven by medtech focus, exclusive material access, and strategic acquisitions. Financial targets were raised, with robust revenue and margin performance, and competitive advantages reinforced by customer relationships and manufacturing expertise.
UFP Technologies, Inc. to Present and Host 1x1 Investor Meetings at the Goldman Sachs 46th Annual Global Healthcare Conference
NEWBURYPORT, Mass., June 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), today announced that Jeffrey Bailly, Chairman and CEO, and Ron Lataille, Sr. Vice President & CFO, will pre...
UFP Technologies Earnings Call Transcript: Q1 2025
Revenue rose 41% and EPS 35% year-over-year, led by 50% growth in the medical segment, especially safe patient handling. New programs and acquisitions drive future growth, with minimal expected tariff impact and continued expansion in the Dominican Republic.
UFP Technologies Announces Record Q1 Results
NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today report...
UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025
NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ: UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and o...
UFP Technologies to Present and Host Investor Meetings at the KeyBanc Capital Healthcare Forum
NEWBURYPORT, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging prima...